For research use only. Not for therapeutic Use.
Pasiniazid(Cat No.:I002591)is an anti-tuberculosis agent used in the treatment of multidrug-resistant tuberculosis (MDR-TB). It is a derivative of isoniazid and works by inhibiting the synthesis of mycolic acids in the bacterial cell wall, which are essential for the survival of Mycobacterium tuberculosis. Due to its potent bactericidal activity, Pasiniazid is primarily used in combination therapy for resistant strains of tuberculosis. Its use is often accompanied by monitoring for potential hepatotoxicity and peripheral neuropathy, common side effects associated with anti-TB medications.
Catalog Number | I002591 |
CAS Number | 2066-89-9 |
Molecular Formula | C13H14N4O4 |
Purity | ≥95% |
Target | Bacterial |
Solubility | 10 mM in DMSO |
Storage | Room temperature |
IUPAC Name | 4-amino-2-hydroxybenzoic acid;pyridine-4-carbohydrazide |
InChI | InChI=1S/C7H7NO3.C6H7N3O/c8-4-1-2-5(7(10)11)6(9)3-4;7-9-6(10)5-1-3-8-4-2-5/h1-3,9H,8H2,(H,10,11);1-4H,7H2,(H,9,10) |
InChIKey | RKPHTRVPGYGVQD-UHFFFAOYSA-N |
SMILES | C1=CC(=C(C=C1N)O)C(=O)O.C1=CN=CC=C1C(=O)NN |
Reference | <p style=/line-height:25px/> |